1987 Nobel Prize in Physiology or Medicine β Tonegawa, the Secret of Combining 1,000 Genes to Create 1 Billion Antibodies
What You Will Learn in This Article
You will understand the answer to the question: How does our body accurately create antibodies against antigens it encounters for the first time? Susumu Tonegawa revealed the genetic mechanism by which B lymphocytes create nearly 1 billion different antibodies using only about 1,000 gene segments. The answer lies in gene cutting and recombination β a discovery that directly challenged the then-prevailing scientific notion that "genes have a stable structure." We will also explore how this discovery laid the foundation for CAR-T cell therapy, phage display antibody libraries, vaccine design, and autoimmune disease diagnosis.
A Story Different from Common Sense β Genes Can Be Recombined
Let's imagine the challenges faced by our body's immune system. The number of pathogens and foreign substances that humans may encounter throughout their lifetime is virtually infinite. Bacteria, viruses, fungi, parasites, industrial chemicals, new vaccine antigens β new infectious diseases emerge every year. Yet, our immune system can create antibodies that specifically bind to antigens it encounters for the first time within a few weeks. It's as if it has already anticipated all potential invaders in the world.
There is an inconsistency in this scenario. The human genome has about 20,000 genes. If each antibody molecule corresponds to one gene, then the number of antibody types that humans can produce should be limited to about 20,000. However, in reality, our immune system can create nearly 1 billion different antibodies. How is this combinatorial explosion possible?
Until the mid-1970s, the scientific community debated this issue with several hypotheses. One prominent hypothesis was that each B cell has a different set of genes. However, this hypothesis directly contradicted a fundamental principle of genetics: all somatic cells have the same genes.
Tonegawa's answer was dramatic. B lymphocytes rearrange their own genes through cutting and recombination during maturation. The antibody gene is divided into several segments (V, D, J segments), and one of these segments is randomly selected and combined to create the complete antibody gene. The number of combinations is in the millions, and further diversity is created by randomly adding or deleting a few nucleotides at the recombination site. Ultimately, this allows for the creation of 1 billion different antibodies.
In the language of computer science, this is a perfect example of compile-time code generation or template metaprogramming. There is a V segment library (about 40), a D segment library (about 25), and a J segment library (about 6), and when a B cell matures, it randomly selects one from each library and combines them to create a complete function (antibody).
Mathematically, 40 Γ 25 Γ 6 = 6,000 combinations (for the heavy chain). When combined with light chain combinations, random nucleotide insertions at the junction, and subsequent somatic hypermutation, the number of possible antibodies exceeds 1 billion. Generating a near-infinite number of functions combinatorially from a finite code.
The significance of this discovery lies in its overturning of fundamental concepts in genetics. If McClintock (1983 Nobel Prize) demonstrated gene movement through transposons, Tonegawa demonstrated that specific cells programmatically rearrange their own genes during normal development.
The Context of the Times β The Decisive Year for Korean Democratization and the Beginning of the End of the Cold War
1987 was one of the most decisive years in modern Korean history.
On January 14, Park Jong-chul, a Seoul National University student, died during waterboarding at the Namyeong-dong detention center. The police's initial attempt to cover up the incident β "he died after being hit lightly" β became a symbol of the era's tragedy. After the truth was revealed, public outrage exploded. On April 13, President Chun Doo-hwan's constitutional amendment (April 13 Amendment), which rejected the public's demand for constitutional revision, led to the outbreak of the June Democratic Uprising, starting with the National Assembly on June 10.
On June 9, Lee Han-yeol, a Yonsei University student, fell into a coma after being hit by a tear gas canister (died on July 5), and this photo was broadcast worldwide, becoming a symbol of the uprising. On June 26, the National Peace March was attended by 1.3 million people nationwide. On June 29, the ruling party's presidential candidate, Roh Tae-woo, announced the 6.29 Declaration, which accepted the direct presidential election system β effectively ending 30 years of military rule. In the December presidential election, Roh Tae-woo was elected due to the opposition's division, but the actual recovery of Korean democracy occurred in this year.
In the same year, on November 29, Korean Air Flight 858 exploded in mid-air over the Indian Ocean, killing all 115 passengers and crew. It was revealed to be a bombing by North Korean agents Kim Hyun-hee and Kim Seung-il, who were aiming to disrupt the 1988 Seoul Olympics, and international pressure on North Korea was strengthened.
In international politics, the US-Soviet INF Treaty was signed on December 8, with Reagan and Gorbachev signing in Washington. This treaty eliminated all intermediate- and short-range nuclear missiles and marked a decisive turning point in the end of the Cold War. On the other hand, on October 19, "Black Monday" in New York β the Dow Jones fell by 22.6% in one day, exposing the vulnerability of the world financial market. IBM PS/2 was released, and Stephen Hawking's "A Brief History of Time" was published (March).
In this tumultuous year, the Nobel Committee recognized a scientist who elucidated the combinatorial code generation mechanism of the immune system. It was in the year when Korea was recombining its system into democracy, that the discovery of how our body's immune system recombines genes to create a defense library was recognized.
Susumu Tonegawa β From Nagoya to MIT
Susumu Tonegawa (1939β) is a Japanese-American geneticist. Born in Nagoya, Japan, in 1939, he majored in chemistry at Kyoto University and received his Ph.D. from the University of California, San Diego (UCSD) in 1969. He then worked as a researcher at the Basel Institute for Immunology in Switzerland from 1971 β the same institute founded by Jerne, who won the Nobel Prize in 1984. Since 1981, he has been a professor at the Massachusetts Institute of Technology (MIT), where he expanded his research focus to brain cognitive neuroscience.
Tonegawa's Nobel Prize-winning work was done during his time at the Basel Institute (1971β1981). At the time, he was immersed in the unsolved problem of antibody diversity, and he reached a point where restriction enzymes and DNA recombination technology β the discoveries of Smith, Nathans, and Arber (1978 Nobel Prize) β became available as mature tools. He had identified a problem to tackle when the necessary tools were ready.
The Decisive Experiment β Comparing the DNA of Embryonic Cells and Mature B Cells
Tonegawa's experimental design was straightforward. If genes are rearranged, then the DNA patterns of embryonic cells (cells that have not yet produced antibodies) and mature B cells (cells that produce antibodies) should differ when the DNA is cut with restriction enzymes.
The method was a new technique called Southern blotting. DNA fragments cut with restriction enzymes are separated by gel electrophoresis, and specific gene regions are detected with a radioactive probe. Then, it was confirmed whether the band patterns corresponding to the antibody gene differ between the two types of cells.
The results were dramatic. In embryonic cells, the segments of the antibody gene (V, J) appeared in several bands that were far apart, but in mature B cells, these segments were observed to be combined into one band. In other words, DNA recombination physically occurred during maturation.
Further detailed gene analysis revealed that the antibody heavy chain is made by the combination of four segments: V (variable) - D (diversity) - J (joining) - C (constant), and the light chain is made by the combination of three segments: V - J - C. One segment is randomly selected from each library β combined β a complete antibody gene is created.
This recombination was later found to be a process in which two proteins, RAG1 and RAG2, cut and paste specific recognition sequences (RSS, recombination signal sequences). The fact that RAG1/RAG2 evolved from a family of transposon enzymes β McClintock's discovery and Tonegawa's discovery are evolutionarily connected β is now considered one of the most beautiful discoveries in genetics.
CS Framework β Combinatorial Code Generation and Library Compilation
If we reconstruct the antibody diversity system in the language of computer science, we get the following diagram.
Segment Library: V, D, and J segments are stored in the genome like a library of source code snippets. Each segment is responsible for a part of the function. V accounts for most of the antigen-binding region, J is for finishing the binding region, and D is for inserting intermediate diversity.
Compile-time Code Generation: When a B cell matures, the RAG1/RAG2 enzyme acts as a compiler. It randomly selects a segment from the library and physically combines it β this is source code-level recombination. The completed function (antibody gene) is a specialized tool that is expressed only in that cell.
Combinatorial Explosion: 40 V Γ 25 D Γ 6 J = 6,000 heavy chain combinations. When combined with the light chain, the number increases even more. Adding diversity at the junction (N-region addition, P-nucleotides) can expand it to 10^11.
Variable Region vs. Constant Region: Antibodies are divided into a V (variable) region and a C (constant) region. V is the user-defined code (target specificity), and C is the standard library (effector function). By combining the same target specificity with different C regions, the effector function of the antibody changes from IgM to IgG or IgA. This is close to partial application in functional programming.
Somatic Hypermutation = Runtime Fine-tuning: Even after the initial recombination, activated B cells accumulate point mutations in the antibody gene (mediated by activation-induced cytidine deaminase, AID). This is a learning algorithm that is fine-tuned at runtime to increase the binding strength to the antigen.
Hybridoma vs. Recombinant Library: The hybridoma technology of the 1984 Nobel Prize is a method for mass-producing specific antibodies. After Tonegawa's discovery, phage display antibody library technology (1990~) was developed, which recombines genes randomly in vitro to screen for the desired antibody. The phage library reproduces the combinatorial explosion of the natural immune system on a laboratory scale.
This analogy is not perfect. The recombination within cells is probabilistic and has controlled directionality, and there is a safety mechanism that causes the cell to die if an error occurs. It is much more sophisticated than simple random combination.
Academic Impact: Understanding Autoimmunity, Immunodeficiency, and Targeted Therapies
Following Donega's discovery, the understanding of immunology underwent a fundamental transformation.
Understanding Severe Combined Immunodeficiency (SCID): Defects in the RAG1/RAG2 genes prevent antibody recombination and T-cell receptor recombination, leading to severe immunodeficiency. David Vetter, known as the "bubble boy," was a case of this type. Subsequently, gene therapy opened up the possibility of treating SCID.
Understanding Autoimmune Diseases: During the recombination process, antibodies that recognize self-antigens can be produced, and there are mechanisms of central and peripheral tolerance to eliminate them. When this tolerance breaks down, autoimmune diseases such as rheumatoid arthritis, lupus, and multiple sclerosis occur.
Diagnosis of Lymphoma: Lymphomas, in which specific B-cell clones proliferate excessively, are diagnosed by examining the clonality of recombined antibody genes. In clinical pathology, immunoglobulin gene rearrangement analysis is a standard diagnostic tool.
CAR-T Cell Therapy: The pinnacle application of Donega's discovery. This therapy involves harvesting a patient's T cells, manipulating them to express T-cell receptors with antibody specificity, and then re-infusing them. FDA-approved CAR-T cell therapies such as Kymriah (2017) and Yescarta (2017) are now standard treatments for CD19-targeted B-cell lymphomas.
Antibody Library Technology: With the advent of phage display (Gregory Winter, 2018 Nobel Prize in Chemistry), it became possible to create fully human antibodies in the laboratory, outside of the natural immune system. Adalimumab (Humira) and trastuzumab are examples of technologies derived from this.
T-cell Receptor (TCR) Diversity: The principles of Donega's discovery also apply to T-cell receptors. TCR recombination, TCR diversity, and TCR repertoire analysis are now standard tools in immunology.
Continuity and Relevance in Korea
In Korea, the impact of this lineage is also evident. From the late 1990s, immunology laboratories at Seoul National University, Yonsei University, and KAIST actively conducted research on V(D)J recombination, TCR diversity analysis, and the genetics of autoimmune diseases.
Introduction of CAR-T Cell Therapy at Seoul National University Hospital: In 2021, Kymriah was introduced in Korea, becoming a standard treatment for pediatric acute lymphoblastic leukemia and relapsed/refractory large B-cell lymphoma. Seoul Asan Medical Center, Samsung Medical Center, and Severance Hospital are also sequentially introducing this therapy, and today, Korea's CAR-T cell therapy outcomes are among the best in the world.
The roots of the domestic antibody industry also lie here. Celltrion and Samsung Bioepis's antibody biosimilar production technology is a combination of hybridoma technology (1984 Nobel Prize) and recombinant antibody library technology (based on Donega's discovery). In major clinical pathology laboratories in Korea, immunoglobulin gene rearrangement assays are standardized for the diagnosis of lymphoma and leukemia.
Why is it Important?
What Donega left behind is the establishment of the idea that "the genome is not static, and specific cells are programmed to recombine their genes."
The principle that infinite diversity can be created from a finite code is the very beauty of system design. Nature discovered combinatorial explosion evolutionarily, and humans have understood it and reproduced it in the laboratory through phage display and CAR-T cell therapy. It is a representative example of human technology learning from nature's algorithms.
The confluence of era and tools is also symbolic of this achievement. Donega addressed the long-standing problem of antibody diversity at a time when restriction enzymes (1978 Nobel Prize) and DNA recombination technology were maturing. It is a case study of how the combination of mature tools and clear questions can be so powerful.
The trajectory of a Japanese-born scientist, from a European research institute to the American MIT, symbolizes the internationality of science in the late 20th century. His life path, starting in Nagoya and passing through UCSD, Basel, and MIT, embodies the global nature of scholarship.
After this achievement, the flow of immunology and genetics continued as follows:
- 1990 Phage Display β Gregory Winter et al., later the 2018 Nobel Prize in Chemistry
- 1996 Doherty and Zinkernagel β MHC-restricted cellular immunity
- 2011 Beutler, Hoffmann, and Steinman β Innate immunity and dendritic cells
- 2018 Allison and Honjo β CTLA-4 and PD-1 immune checkpoint inhibitors
The clinical and industrial applications of these discoveries:
- CAR-T cell therapy β Kymriah (2017) and Yescarta (2017)
- Phage display, fully human antibodies β Adalimumab (Humira, 2002)
- Immune gene testing β Standard for diagnosis of lymphoma and leukemia
- T-cell receptor library β TCR-T cell therapy
β Previous: [1986 β Cohen and Levi-Montalcini] (/wetbench/nobel-physiology-1986) β Next: [1988 β Batch 8 in progress]